Status:
COMPLETED
Is Neutrophil to Lymphocyte Ratio a Prognostic Factor of Sepsis in Newborns With Operated Neural Tube Defects?
Lead Sponsor:
Tepecik Training and Research Hospital
Conditions:
Neural Tube Defects
Newborn Sepsis
Eligibility:
All Genders
Up to 28 years
Brief Summary
We aimed to investigate whether Neutrophil Lymphocyte Ratio is a Prognostic Factor of Sepsis in Newborns with operated Neural Tube Defects?
Eligibility Criteria
Inclusion
- \<28 days diagnosed with with neural Tüpe Defects To be operated
Exclusion
- \>28 days
Key Trial Info
Start Date :
January 1 2015
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 30 2018
Estimated Enrollment :
57 Patients enrolled
Trial Details
Trial ID
NCT04135274
Start Date
January 1 2015
End Date
December 30 2018
Last Update
October 22 2019
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.